➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Moodys
AstraZeneca
Harvard Business School
Merck

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Landiolol


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Landiolol?

Landiolol is an investigational drug.

There have been 4 clinical trials for Landiolol. The most recent clinical trial was a Phase 1 trial, which was initiated on December 13th 2019.

The most common disease conditions in clinical trials are Atrial Fibrillation and [disabled in preview]. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, Hospices Civils de Lyon, and University Hospital, Caen.

There are two hundred and five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Landiolol
TitleSponsorPhase
Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac SurgeryUniversity Hospital, CaenPhase 4
Landiolol in Postoperative Atrial FibrillationHospices Civils de LyonPhase 3
Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy VolunteersAOP Orphan Pharmaceuticals AGPhase 1

See all Landiolol clinical trials

Clinical Trial Summary for Landiolol

Top disease conditions for Landiolol
Top clinical trial sponsors for Landiolol

See all Landiolol clinical trials

US Patents for Landiolol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Landiolol   Start Trial Branched 3-phenylpropionic acid derivatives and their use BAYER PHARMA AKTIENGESELLSCHAFT (Monheim, DE)   Start Trial
Landiolol   Start Trial Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Start Trial
Landiolol   Start Trial 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKinsey
Mallinckrodt
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.